{"recordsFiltered":48247,"recordsTotal":48247,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=20700","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=20100","results":[{"registry_id":"NCT04682405","publication_url":"https://clinicaltrials.gov/study/NCT04682405","title":"A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)","has_exemption":false,"start_date":"2021-05-05","completion_date":"2022-11-11","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02545127","publication_url":"https://clinicaltrials.gov/study/NCT02545127","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Exploring the Efficacy and Safety of Intra-nasal Administration of Merotocin in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production","has_exemption":false,"start_date":"2021-05-28","completion_date":"2022-11-11","has_results":true,"results_due":true,"sponsor_name":"Ferring Pharmaceuticals","sponsor_slug":"ferring-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04776629","publication_url":"https://clinicaltrials.gov/study/NCT04776629","title":"A Multi-Center, Randomized, Double-Blind, Placebo-controlled Proof-of-Activity Study With Orticumab in Subjects With Moderate-to-Severe Psoriasis and Cardiometabolic Risk Factors","has_exemption":false,"start_date":"2021-06-30","completion_date":"2022-11-11","has_results":false,"results_due":true,"sponsor_name":"Abcentra","sponsor_slug":"abcentra","status":"reported-late","is_pact":false,"days_late":856},{"registry_id":"NCT04984278","publication_url":"https://clinicaltrials.gov/study/NCT04984278","title":"A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis","has_exemption":false,"start_date":"2021-08-16","completion_date":"2022-11-11","has_results":true,"results_due":true,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05314816","publication_url":"https://clinicaltrials.gov/study/NCT05314816","title":"Clinical Impact of a Multiplex PCR Blood Culture Identification Panel in Early Identification of Positive Blood Cultures in Pediatric Patients in Guatemala","has_exemption":false,"start_date":"2022-04-07","completion_date":"2022-11-11","has_results":true,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported-late","is_pact":false,"days_late":87},{"registry_id":"NCT05357248","publication_url":"https://clinicaltrials.gov/study/NCT05357248","title":"Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH","has_exemption":false,"start_date":"2022-04-10","completion_date":"2022-11-11","has_results":false,"results_due":true,"sponsor_name":"Better Therapeutics","sponsor_slug":"better-therapeutics","status":"overdue","is_pact":false,"days_late":866},{"registry_id":"NCT04083170","publication_url":"https://clinicaltrials.gov/study/NCT04083170","title":"Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR5Δ32 Homozygous or Heterozygous Cord Blood Unit in Patients With HIV and Hematological Malignancies","has_exemption":true,"start_date":"2022-10-06","completion_date":"2022-11-11","has_results":true,"results_due":true,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04613830","publication_url":"https://clinicaltrials.gov/study/NCT04613830","title":"Continuous Erector Spinae Plane Local Anesthetic Infusion for Postoperative Analgesia in Pediatric Patients Undergoing Nephrectomy: Randomized Controlled Study","has_exemption":false,"start_date":"2020-11-20","completion_date":"2022-11-12","has_results":false,"results_due":true,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"overdue","is_pact":false,"days_late":865},{"registry_id":"NCT04654689","publication_url":"https://clinicaltrials.gov/study/NCT04654689","title":"Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients","has_exemption":false,"start_date":"2021-11-20","completion_date":"2022-11-12","has_results":false,"results_due":true,"sponsor_name":"Fundación Universidad Católica de Valencia San Vicente Mártir","sponsor_slug":"fundacion-universidad-catolica-de-valencia-san-vicente-martir","status":"overdue","is_pact":false,"days_late":865},{"registry_id":"NCT05430243","publication_url":"https://clinicaltrials.gov/study/NCT05430243","title":"Empagliflozin in the Management of Cirrhosis-related Refractory Ascites: a Randomized Controlled Trial","has_exemption":false,"start_date":"2022-04-21","completion_date":"2022-11-12","has_results":false,"results_due":true,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"overdue","is_pact":false,"days_late":865},{"registry_id":"NCT05450003","publication_url":"https://clinicaltrials.gov/study/NCT05450003","title":"Effect of Different Irrigation Activating Techniques on Irrigant Penetration Depth Into Root Canals and on Post-Operative Pain After Single-Visit Endodontic Treatment","has_exemption":false,"start_date":"2022-08-01","completion_date":"2022-11-12","has_results":false,"results_due":true,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"reported-late","is_pact":false,"days_late":254},{"registry_id":"NCT04099836","publication_url":"https://clinicaltrials.gov/study/NCT04099836","title":"Single Arm Phase 2 Trial of Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib (TOP 1901)","has_exemption":false,"start_date":"2020-07-09","completion_date":"2022-11-13","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02399085","publication_url":"https://clinicaltrials.gov/study/NCT02399085","title":"A Phase II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and Efficacy of Lenalidomide Combined With MOR00208 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL)","has_exemption":false,"start_date":"2016-03-29","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"MorphoSys AG","sponsor_slug":"morphosys-ag","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03724084","publication_url":"https://clinicaltrials.gov/study/NCT03724084","title":"A Phase 1b/2 Study of Pinometostat in Combination With Standard Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia With MLL Rearrangement","has_exemption":false,"start_date":"2019-04-10","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":17},{"registry_id":"NCT04031833","publication_url":"https://clinicaltrials.gov/study/NCT04031833","title":"Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial","has_exemption":false,"start_date":"2019-10-24","completion_date":"2022-11-14","has_results":false,"results_due":true,"sponsor_name":"Matinas BioPharma Nanotechnologies, Inc.","sponsor_slug":"matinas-biopharma-nanotechnologies-inc","status":"reported-late","is_pact":false,"days_late":188},{"registry_id":"NCT04530344","publication_url":"https://clinicaltrials.gov/study/NCT04530344","title":"A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo","has_exemption":false,"start_date":"2020-09-24","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04382612","publication_url":"https://clinicaltrials.gov/study/NCT04382612","title":"Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)","has_exemption":false,"start_date":"2020-10-02","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"reported-late","is_pact":false,"days_late":23},{"registry_id":"NCT04453046","publication_url":"https://clinicaltrials.gov/study/NCT04453046","title":"Depleting Exosomes to Improve Response to Immune Therapy in Head and Neck Squamous Cell Cancer: An Early Feasibility Phase I Clinical Trial","has_exemption":false,"start_date":"2020-10-22","completion_date":"2022-11-14","has_results":false,"results_due":true,"sponsor_name":"Aethlon Medical Inc.","sponsor_slug":"aethlon-medical-inc","status":"overdue","is_pact":false,"days_late":863},{"registry_id":"NCT04607148","publication_url":"https://clinicaltrials.gov/study/NCT04607148","title":"A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Intravitreal Injections of FHTR2163 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2020-11-16","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05051982","publication_url":"https://clinicaltrials.gov/study/NCT05051982","title":"SedLine EEG-Guided Depth of Anesthesia: Effect of Anesthetic Dosage","has_exemption":false,"start_date":"2021-06-30","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04858178","publication_url":"https://clinicaltrials.gov/study/NCT04858178","title":"Transcutaneous Spinal Neuromodulation to Normalize Autonomic Phenotypes","has_exemption":false,"start_date":"2022-02-17","completion_date":"2022-11-14","has_results":false,"results_due":true,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05093790","publication_url":"https://clinicaltrials.gov/study/NCT05093790","title":"A Phase 2a Single Dose Study to Evaluate the Effect of BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in an Ex Vivo Thrombosis Chamber Model in Patients With Stable Coronary Artery Disease and Healthy Participants","has_exemption":false,"start_date":"2022-03-25","completion_date":"2022-11-14","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05267301","publication_url":"https://clinicaltrials.gov/study/NCT05267301","title":"Open Label Post-market Evaluation of Orally Dosed AlmegaPL on Cholesterol and Cardio-metabolic Parameters.","has_exemption":false,"start_date":"2022-05-11","completion_date":"2022-11-14","has_results":false,"results_due":true,"sponsor_name":"Qualitas Health","sponsor_slug":"qualitas-health","status":"overdue","is_pact":false,"days_late":863},{"registry_id":"NCT04595903","publication_url":"https://clinicaltrials.gov/study/NCT04595903","title":"Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device","has_exemption":false,"start_date":"2022-06-01","completion_date":"2022-11-14","has_results":false,"results_due":true,"sponsor_name":"Aethlon Medical Inc.","sponsor_slug":"aethlon-medical-inc","status":"overdue","is_pact":false,"days_late":863},{"registry_id":"NCT02582775","publication_url":"https://clinicaltrials.gov/study/NCT02582775","title":"MT2015-20: Biochemical Correction of Severe Epidermolysis Bullosa by Allogeneic Cell Transplantation and Serial Donor Mesenchymal Cell Infusions","has_exemption":false,"start_date":"2016-03-31","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported-late","is_pact":true,"days_late":75},{"registry_id":"NCT06360575","publication_url":"https://clinicaltrials.gov/study/NCT06360575","title":"MATCH Treatment Subprotocol C2: Crizotinib in Patients With Tumors With MET Exon 14 Deletion","has_exemption":false,"start_date":"2016-07-20","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":839},{"registry_id":"NCT06357975","publication_url":"https://clinicaltrials.gov/study/NCT06357975","title":"MATCH Treatment Subprotocol C1: Crizotinib in Patients With Tumors With MET Amplification","has_exemption":false,"start_date":"2016-07-29","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":838},{"registry_id":"NCT03207009","publication_url":"https://clinicaltrials.gov/study/NCT03207009","title":"A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects With Transfusion-dependent β-Thalassemia by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector in Subjects ≤50 Years of Age","has_exemption":false,"start_date":"2017-06-08","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Genetix Biotherapeutics Inc.","sponsor_slug":"genetix-biotherapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03252093","publication_url":"https://clinicaltrials.gov/study/NCT03252093","title":"A Randomized, Placebo-controlled, Double Blind Evaluation of the Safety and Efficacy of Angiotensin 1-7 (Ang-(1-7)) to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery.","has_exemption":false,"start_date":"2017-07-20","completion_date":"2022-11-15","has_results":false,"results_due":true,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"overdue","is_pact":false,"days_late":862},{"registry_id":"NCT03958045","publication_url":"https://clinicaltrials.gov/study/NCT03958045","title":"Phase II Study of Combination Rucaparib With Nivolumab in Platinum-Sensitive Small Cell Lung Carcinoma Patients as Maintenance After Induction Therapy With Platinum Doublet","has_exemption":false,"start_date":"2019-09-04","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Zhonglin Hao","sponsor_slug":"zhonglin-hao","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04608773","publication_url":"https://clinicaltrials.gov/study/NCT04608773","title":"Evaluation of Two Mouth Sprays for Post-irradiation Xerostomia in Head and Neck Cancer Survivors: a Randomized, Double-blind Clinical Trial","has_exemption":false,"start_date":"2021-01-14","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Jonas Johnson","sponsor_slug":"jonas-johnson","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04794491","publication_url":"https://clinicaltrials.gov/study/NCT04794491","title":"A Phase 4 Multicenter, Open-label, Single-arm Study of Safety, Tolerability, Effectiveness and Treatment Optimization in Participants Switching From Xyrem to XYWAV for the Treatment of Narcolepsy","has_exemption":false,"start_date":"2021-03-22","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04798482","publication_url":"https://clinicaltrials.gov/study/NCT04798482","title":"Effect of Dexmedetomidine of Gastrointestinal Motility","has_exemption":false,"start_date":"2021-09-14","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"reported-late","is_pact":false,"days_late":138},{"registry_id":"NCT05132127","publication_url":"https://clinicaltrials.gov/study/NCT05132127","title":"An Open-label Study for Sutimlimab in Participants With Cold Agglutinin Disease (CAD) Who Have Completed the CARDINAL Study (BIVV009-03/EFC16215, Part B) or CADENZA Study (BIVV009-04/EFC16216, Part B) in Japan","has_exemption":false,"start_date":"2021-11-11","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05386147","publication_url":"https://clinicaltrials.gov/study/NCT05386147","title":"Pilot Study to Observe Effects of Flourish HEC Vaginal Care System on Vaginal Microbiome in Women With Recurrent Bacterial Vaginosis","has_exemption":false,"start_date":"2021-12-22","completion_date":"2022-11-15","has_results":false,"results_due":true,"sponsor_name":"Vaginal Biome Science","sponsor_slug":"vaginal-biome-science","status":"overdue","is_pact":false,"days_late":862},{"registry_id":"NCT05050149","publication_url":"https://clinicaltrials.gov/study/NCT05050149","title":"A Multicenter, Phase 2, Open-Label Study Evaluating The Safety And Efficacy of Sirolimus 3.9% Topical Gel (PTX-022) In The Treatment of Microcystic Lymphatic Malformations","has_exemption":false,"start_date":"2022-01-13","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Palvella Therapeutics, Inc.","sponsor_slug":"palvella-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":404},{"registry_id":"NCT05769452","publication_url":"https://clinicaltrials.gov/study/NCT05769452","title":"Effect of Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications in Pediatric Hematology and Oncology Patients","has_exemption":false,"start_date":"2022-04-01","completion_date":"2022-11-15","has_results":false,"results_due":true,"sponsor_name":"Gülçin Özalp Gerçeker","sponsor_slug":"gulcin-ozalp-gerceker","status":"overdue","is_pact":false,"days_late":862},{"registry_id":"NCT04978038","publication_url":"https://clinicaltrials.gov/study/NCT04978038","title":"Fourth Dose of Pfizer mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities","has_exemption":false,"start_date":"2022-08-01","completion_date":"2022-11-15","has_results":false,"results_due":true,"sponsor_name":"Mark Loeb","sponsor_slug":"mark-loeb","status":"overdue","is_pact":false,"days_late":862},{"registry_id":"NCT05351554","publication_url":"https://clinicaltrials.gov/study/NCT05351554","title":"A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With an Open-label Cohort to Assess the Safety, Tolerability, and Efficacy of Namilumab in Subjects With Active Cardiac Sarcoidosis","has_exemption":true,"start_date":"2022-08-23","completion_date":"2022-11-15","has_results":true,"results_due":true,"sponsor_name":"Kinevant Sciences GmbH","sponsor_slug":"kinevant-sciences-gmbh","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05514262","publication_url":"https://clinicaltrials.gov/study/NCT05514262","title":"The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination","has_exemption":false,"start_date":"2022-08-30","completion_date":"2022-11-15","has_results":false,"results_due":true,"sponsor_name":"Uludag University","sponsor_slug":"uludag-university","status":"overdue","is_pact":false,"days_late":862},{"registry_id":"NCT02494544","publication_url":"https://clinicaltrials.gov/study/NCT02494544","title":"A Prospective, Multicenter Study to Evaluate Functional Outcome After Knee Replacement","has_exemption":false,"start_date":"2015-07-01","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Restor3D","sponsor_slug":"restor3d","status":"reported-late","is_pact":true,"days_late":645},{"registry_id":"NCT02661672","publication_url":"https://clinicaltrials.gov/study/NCT02661672","title":"INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage: A Prospective Multicenter Registry","has_exemption":false,"start_date":"2016-10-14","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"J. Mocco","sponsor_slug":"j-mocco","status":"reported-late","is_pact":true,"days_late":550},{"registry_id":"NCT03341962","publication_url":"https://clinicaltrials.gov/study/NCT03341962","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis","has_exemption":false,"start_date":"2018-03-15","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Immunic AG","sponsor_slug":"immunic-ag","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03782259","publication_url":"https://clinicaltrials.gov/study/NCT03782259","title":"Effects of SGLT-2 Inhibition With Dapagliflozin on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI With T1- and T2-mapping in Patients With Type-2 Diabetes","has_exemption":false,"start_date":"2019-02-26","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03861273","publication_url":"https://clinicaltrials.gov/study/NCT03861273","title":"Phase 3, Open-label, Single-arm Study to Evaluate Efficacy and Safety of FIX Gene Transfer With PF-06838435 (rAAV-Spark100-hFIX-R338L) in Adult Male Participants With Moderately Severe to Severe Hemophilia B (FIX:C ≤2%) (BeneGene-2)","has_exemption":false,"start_date":"2019-07-29","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03925532","publication_url":"https://clinicaltrials.gov/study/NCT03925532","title":"A Phase II Multicenter, Single Arm, Open-Label Trial to Evaluate the Efficacy and Safety of Denosumab in Treatment of Post-Allogenic Hematopoietic Stem Cell Transplant Bone Loss","has_exemption":false,"start_date":"2019-12-19","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"reported-late","is_pact":false,"days_late":35},{"registry_id":"NCT04538066","publication_url":"https://clinicaltrials.gov/study/NCT04538066","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment","has_exemption":false,"start_date":"2020-08-30","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Neurotrope Bioscience, Inc.","sponsor_slug":"neurotrope-bioscience-inc","status":"reported-late","is_pact":false,"days_late":41},{"registry_id":"NCT04434092","publication_url":"https://clinicaltrials.gov/study/NCT04434092","title":"A Phase III, Randomized, Open-label, Active-controlled, Multicenter Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors","has_exemption":true,"start_date":"2020-10-08","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04676737","publication_url":"https://clinicaltrials.gov/study/NCT04676737","title":"Phase 2 Study To Determine the Safety and Efficacy of TTHX1114(NM141) on the Regeneration and Migration of Corneal Endothelial Cells in Patients Undergoing DWEK/DSO","has_exemption":false,"start_date":"2021-02-01","completion_date":"2022-11-16","has_results":false,"results_due":true,"sponsor_name":"Trefoil Therapeutics, Inc.","sponsor_slug":"trefoil-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT04542642","publication_url":"https://clinicaltrials.gov/study/NCT04542642","title":"A Randomized, Controlled, Open-Label, Decentralized Study, to Evaluate Patient Engagement With PEAR-008, a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder","has_exemption":false,"start_date":"2021-05-19","completion_date":"2022-11-16","has_results":false,"results_due":true,"sponsor_name":"Pear Therapeutics, Inc.","sponsor_slug":"pear-therapeutics-inc","status":"overdue","is_pact":false,"days_late":861},{"registry_id":"NCT04808141","publication_url":"https://clinicaltrials.gov/study/NCT04808141","title":"Digital Care Program for Chronic Low Back Pain Versus Conventional Physical Therapy: a Prospective, Randomized Controlled Study","has_exemption":false,"start_date":"2021-05-25","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Sword Health, SA","sponsor_slug":"sword-health-sa","status":"reported-late","is_pact":false,"days_late":390},{"registry_id":"NCT04939428","publication_url":"https://clinicaltrials.gov/study/NCT04939428","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19","has_exemption":false,"start_date":"2021-08-11","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05480514","publication_url":"https://clinicaltrials.gov/study/NCT05480514","title":"Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses","has_exemption":false,"start_date":"2022-08-27","completion_date":"2022-11-16","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05777057","publication_url":"https://clinicaltrials.gov/study/NCT05777057","title":"Comparison Between KAVO DIAGNOdent and Digital Radiography in Occlusal Caries Detection (A Diagnostic Accuracy Study)","has_exemption":false,"start_date":"2022-11-16","completion_date":"2022-11-16","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":861},{"registry_id":"NCT02272998","publication_url":"https://clinicaltrials.gov/study/NCT02272998","title":"Phase II Study of Ponatinib for Advanced Cancers With Genomic Alterations in Fibroblastic Growth Factor Receptor (FGFR) and Other Genomic Targets (KIT, PDGFRá, RET FLT3, ABL1)","has_exemption":false,"start_date":"2015-02-24","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Sameek Roychowdhury","sponsor_slug":"sameek-roychowdhury","status":"reported-late","is_pact":true,"days_late":445},{"registry_id":"NCT03197922","publication_url":"https://clinicaltrials.gov/study/NCT03197922","title":"A Multidisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders","has_exemption":true,"start_date":"2017-10-25","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03432364","publication_url":"https://clinicaltrials.gov/study/NCT03432364","title":"A Phase 1/2, Open-label, Single-arm Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous Hematopoietic Stem Cell Transplant for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)","has_exemption":false,"start_date":"2018-03-29","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Sangamo Therapeutics","sponsor_slug":"sangamo-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03270956","publication_url":"https://clinicaltrials.gov/study/NCT03270956","title":"A Phase II, Open-Label Safety and Tolerability Study of an Renal Autologous Cell Therapy (REACT) in Patients With Type 2 Diabetes and Chronic Kidney Disease (REGEN-003)","has_exemption":false,"start_date":"2018-04-25","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Prokidney","sponsor_slug":"prokidney","status":"reported-late","is_pact":false,"days_late":453},{"registry_id":"NCT03834948","publication_url":"https://clinicaltrials.gov/study/NCT03834948","title":"A Phase 1/2 Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AO-176","has_exemption":false,"start_date":"2019-02-04","completion_date":"2022-11-17","has_results":false,"results_due":true,"sponsor_name":"Arch Oncology","sponsor_slug":"arch-oncology","status":"overdue","is_pact":false,"days_late":860},{"registry_id":"NCT03660930","publication_url":"https://clinicaltrials.gov/study/NCT03660930","title":"A Phase 1/2 Study of Nab-Sirolimus With Pazopanib (VOTRIENT®) in Patients With Advanced Nonadipocytic Soft-Tissue Sarcomas","has_exemption":false,"start_date":"2019-04-01","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03840967","publication_url":"https://clinicaltrials.gov/study/NCT03840967","title":"A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) High Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma","has_exemption":false,"start_date":"2019-07-09","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Shadia Jalal, MD","sponsor_slug":"shadia-jalal-md","status":"reported-late","is_pact":false,"days_late":171},{"registry_id":"NCT04233879","publication_url":"https://clinicaltrials.gov/study/NCT04233879","title":"A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants","has_exemption":false,"start_date":"2020-02-28","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04393779","publication_url":"https://clinicaltrials.gov/study/NCT04393779","title":"Beating Heart Mitral Valve REPair With the HARPOON™ System: ReaL World Outcomes From a multICenter observATional European Registry","has_exemption":false,"start_date":"2020-10-02","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT04730947","publication_url":"https://clinicaltrials.gov/study/NCT04730947","title":"Evaluation of the Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction (CAMEO-DAPA): A Phase II, Prospective, Double-Blind Study","has_exemption":false,"start_date":"2021-02-24","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04896385","publication_url":"https://clinicaltrials.gov/study/NCT04896385","title":"A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Mechanism of Action of Ruxolitinib Cream for Vitiligo","has_exemption":false,"start_date":"2021-06-23","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05005390","publication_url":"https://clinicaltrials.gov/study/NCT05005390","title":"Comparison of Effectiveness of Mask Ventilation and Endotracheal Tube in Pharynx (TTIP) in Patients With Potential Difficult Airway:A Prospective Randomized and Blinded Trial.","has_exemption":false,"start_date":"2021-07-26","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04716413","publication_url":"https://clinicaltrials.gov/study/NCT04716413","title":"Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Who Are Undergoing Ambulatory Surgery- a Case Series","has_exemption":false,"start_date":"2021-09-27","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04776954","publication_url":"https://clinicaltrials.gov/study/NCT04776954","title":"Comparison of Normothermia Maintenance Between Resistive Blanket and Forced Air Warming Systems in Renal Transplant Surgery","has_exemption":false,"start_date":"2021-09-27","completion_date":"2022-11-17","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":false,"days_late":157},{"registry_id":"NCT05119686","publication_url":"https://clinicaltrials.gov/study/NCT05119686","title":"A Phase 2b, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of AR882 Versus Placebo in Gout Patients","has_exemption":true,"start_date":"2021-11-16","completion_date":"2022-11-17","has_results":false,"results_due":true,"sponsor_name":"Arthrosi Therapeutics","sponsor_slug":"arthrosi-therapeutics","status":"overdue","is_pact":false,"days_late":129},{"registry_id":"NCT05322148","publication_url":"https://clinicaltrials.gov/study/NCT05322148","title":"The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye","has_exemption":false,"start_date":"2022-06-03","completion_date":"2022-11-17","has_results":false,"results_due":true,"sponsor_name":"Research Insight LLC","sponsor_slug":"research-insight-llc","status":"overdue","is_pact":false,"days_late":860},{"registry_id":"NCT03523702","publication_url":"https://clinicaltrials.gov/study/NCT03523702","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (SPRINT)","has_exemption":false,"start_date":"2018-08-30","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"reported-late","is_pact":false,"days_late":314},{"registry_id":"NCT03750786","publication_url":"https://clinicaltrials.gov/study/NCT03750786","title":"A Randomized, Multicenter, Parallel-group, Phase III Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer","has_exemption":false,"start_date":"2018-12-18","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Isofol Medical AB","sponsor_slug":"isofol-medical-ab","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03904147","publication_url":"https://clinicaltrials.gov/study/NCT03904147","title":"Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal","has_exemption":false,"start_date":"2019-08-21","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"reported-late","is_pact":false,"days_late":52},{"registry_id":"NCT04076059","publication_url":"https://clinicaltrials.gov/study/NCT04076059","title":"China ARCHES: A Multicenter, Phase 3, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)","has_exemption":false,"start_date":"2019-09-11","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma China, Inc.","sponsor_slug":"astellas-pharma-china-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03991988","publication_url":"https://clinicaltrials.gov/study/NCT03991988","title":"Effects of Montelukast Therapy on Alzheimer's Disease (EMERALD)","has_exemption":false,"start_date":"2019-09-25","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03484819","publication_url":"https://clinicaltrials.gov/study/NCT03484819","title":"Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma","has_exemption":false,"start_date":"2019-12-13","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":13},{"registry_id":"NCT04358224","publication_url":"https://clinicaltrials.gov/study/NCT04358224","title":"The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment","has_exemption":false,"start_date":"2020-09-01","completion_date":"2022-11-18","has_results":false,"results_due":true,"sponsor_name":"Jonathan A. Bernstein, MD","sponsor_slug":"jonathan-a-bernstein-md","status":"overdue","is_pact":false,"days_late":859},{"registry_id":"NCT04662281","publication_url":"https://clinicaltrials.gov/study/NCT04662281","title":"A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1)","has_exemption":true,"start_date":"2020-12-10","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Lexicon Pharmaceuticals","sponsor_slug":"lexicon-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04839380","publication_url":"https://clinicaltrials.gov/study/NCT04839380","title":"An Open-Label, Single-Arm Study to Evaluate the Effect of Ruxolitinib 1.5% Cream on Itch in Adult Participants With Atopic Dermatitis","has_exemption":false,"start_date":"2021-10-12","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05166707","publication_url":"https://clinicaltrials.gov/study/NCT05166707","title":"A Prospective, Single Arm, Open, Single-center, Feasibility Study to Assess the Effectiveness and Safety of Mobile App (OC Free) for Patients With Obsessive-Compulsive Disorder (OCD)","has_exemption":false,"start_date":"2021-10-18","completion_date":"2022-11-18","has_results":false,"results_due":true,"sponsor_name":"BIXINK Therapeutics Co., Ltd.","sponsor_slug":"bixink-therapeutics-co-ltd","status":"overdue","is_pact":false,"days_late":859},{"registry_id":"NCT05027282","publication_url":"https://clinicaltrials.gov/study/NCT05027282","title":"A Prospective Study Evaluating the Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment.","has_exemption":false,"start_date":"2021-10-27","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05213143","publication_url":"https://clinicaltrials.gov/study/NCT05213143","title":"The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine: An Open-label, Single-arm And Multi-center Study for 16 Weeks","has_exemption":false,"start_date":"2021-12-30","completion_date":"2022-11-18","has_results":false,"results_due":true,"sponsor_name":"Sumitomo Pharma (Suzhou) Co., Ltd.","sponsor_slug":"sumitomo-pharma-suzhou-co-ltd","status":"reported-late","is_pact":false,"days_late":542},{"registry_id":"NCT04658095","publication_url":"https://clinicaltrials.gov/study/NCT04658095","title":"A Prospective, Randomized, Multicenter Study To Compare The Safety And Effectiveness Of The OMNI® Surgical System And The iStent Inject In Pseudophakic Eyes With Open Angle Glaucoma. The TRIDENT European Trial","has_exemption":false,"start_date":"2022-01-11","completion_date":"2022-11-18","has_results":true,"results_due":true,"sponsor_name":"Sight Sciences, Inc.","sponsor_slug":"sight-sciences-inc","status":"reported-late","is_pact":false,"days_late":633},{"registry_id":"NCT05553964","publication_url":"https://clinicaltrials.gov/study/NCT05553964","title":"Prospective, Multi-Center, Non-Randomized Study to Evaluate the 3EO Health SARS-CoV-2 Molecular Diagnostic Test","has_exemption":false,"start_date":"2022-10-07","completion_date":"2022-11-18","has_results":false,"results_due":true,"sponsor_name":"3EO Health","sponsor_slug":"3eo-health","status":"overdue","is_pact":false,"days_late":859},{"registry_id":"NCT02581943","publication_url":"https://clinicaltrials.gov/study/NCT02581943","title":"Immune Response in Patients With Recurrent or Metastatic Non-small Cell Lung Cancer and Performance Status of 2 Treated With a Combination of Pembrolizumab and Low Dose Weekly Carboplatin/Paclitaxel","has_exemption":false,"start_date":"2016-06-17","completion_date":"2022-11-19","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":true,"days_late":2},{"registry_id":"NCT04220489","publication_url":"https://clinicaltrials.gov/study/NCT04220489","title":"Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery: A Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2019-12-17","completion_date":"2022-11-19","has_results":true,"results_due":true,"sponsor_name":"Jacques E. Chelly","sponsor_slug":"jacques-e-chelly","status":"reported-late","is_pact":false,"days_late":2},{"registry_id":"NCT04445987","publication_url":"https://clinicaltrials.gov/study/NCT04445987","title":"A Phase 2, Multicenter, Open-Label Study of the Long-Term Safety of ARQ-154 Foam 0.3% in Subjects With Seborrheic Dermatitis","has_exemption":true,"start_date":"2020-06-12","completion_date":"2022-11-19","has_results":true,"results_due":true,"sponsor_name":"Arcutis Biotherapeutics, Inc.","sponsor_slug":"arcutis-biotherapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02862210","publication_url":"https://clinicaltrials.gov/study/NCT02862210","title":"Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia","has_exemption":true,"start_date":"2017-01-27","completion_date":"2022-11-20","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03876457","publication_url":"https://clinicaltrials.gov/study/NCT03876457","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","has_exemption":false,"start_date":"2019-10-11","completion_date":"2022-11-20","has_results":true,"results_due":true,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05701124","publication_url":"https://clinicaltrials.gov/study/NCT05701124","title":"Intravitreal Ranibizumab Injection In Aggressive Retinopathy Of Prematurity Compared With Type 1 Prethreshold Retinopathy Of Prematurity","has_exemption":false,"start_date":"2020-11-20","completion_date":"2022-11-20","has_results":false,"results_due":true,"sponsor_name":"Zagazig University","sponsor_slug":"zagazig-university","status":"overdue","is_pact":false,"days_late":857},{"registry_id":"NCT06152900","publication_url":"https://clinicaltrials.gov/study/NCT06152900","title":"Clinical Evaluation of the Safety and Efficacy of Electronic Stimulation for Non-Invasive Circumferential Reduction and Muscle Toning","has_exemption":false,"start_date":"2021-10-05","completion_date":"2022-11-20","has_results":false,"results_due":true,"sponsor_name":"CynosureLutronic","sponsor_slug":"cynosurelutronic","status":"overdue","is_pact":false,"days_late":857},{"registry_id":"NCT05416866","publication_url":"https://clinicaltrials.gov/study/NCT05416866","title":"Transversus Abdominis Plane Block Plus Quadratus Lumborum Block or Retrolaminar Block of Multiple Injections for Postoperative Analgesia Following Laparoscopic Colorectal Surgery: A Randomized, Double-blind, Controlled Trial","has_exemption":false,"start_date":"2022-06-20","completion_date":"2022-11-20","has_results":false,"results_due":true,"sponsor_name":"dong zhang","sponsor_slug":"dong-zhang","status":"overdue","is_pact":false,"days_late":857},{"registry_id":"NCT03220776","publication_url":"https://clinicaltrials.gov/study/NCT03220776","title":"Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics","has_exemption":false,"start_date":"2017-08-07","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03067571","publication_url":"https://clinicaltrials.gov/study/NCT03067571","title":"An Open-Label, Phase 2 Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome","has_exemption":false,"start_date":"2017-10-27","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03457142","publication_url":"https://clinicaltrials.gov/study/NCT03457142","title":"Phase II Study of Targeting CD28 in Multiple Myeloma With Abatacept (CTLA4-Ig) to Overcome Resistance to Chemotherapy","has_exemption":false,"start_date":"2018-09-11","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"reported-late","is_pact":false,"days_late":106},{"registry_id":"NCT03568422","publication_url":"https://clinicaltrials.gov/study/NCT03568422","title":"A Phase Ib and Open Label Phase II Study of CFI-402257 in Combination With Weekly Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer","has_exemption":false,"start_date":"2019-02-05","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"reported-late","is_pact":false,"days_late":29},{"registry_id":"NCT03763318","publication_url":"https://clinicaltrials.gov/study/NCT03763318","title":"A Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of EQ001 in Subjects With Newly Diagnosed Acute Graft Versus Host Disease","has_exemption":false,"start_date":"2019-07-15","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Equillium","sponsor_slug":"equillium","status":"reported-late","is_pact":false,"days_late":476},{"registry_id":"NCT04358458","publication_url":"https://clinicaltrials.gov/study/NCT04358458","title":"Safety and Efficacy of GEN3009 (DuoHexaBody®-CD37) in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - A First-in-Human, Open-label, Phase 1/2a Dose Escalation Trial With Dose Expansion Cohorts","has_exemption":true,"start_date":"2020-03-13","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04233216","publication_url":"https://clinicaltrials.gov/study/NCT04233216","title":"A Phase 3, Randomized, Clinical Study in HIV-1-Infected Heavily Treatment-Experienced Participants Evaluating the Antiretroviral Activity of Blinded Islatravir (ISL), Doravirine (DOR), and Doravirine/Islatravir (DOR/ISL), Each Compared to Placebo, and the Antiretroviral Activity, Safety, and Tolerability of Open-Label DOR/ISL","has_exemption":false,"start_date":"2020-03-18","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04604132","publication_url":"https://clinicaltrials.gov/study/NCT04604132","title":"A Phase 1b/2 Study of Derazantinib as Monotherapy and Combination Therapy With Paclitaxel, Ramucirumab or Atezolizumab in Patients With HER2-negative Gastric Adenocarcinoma Expressing FGFR2 Genetic Aberrations","has_exemption":false,"start_date":"2020-10-06","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Basilea Pharmaceutica","sponsor_slug":"basilea-pharmaceutica","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04177706","publication_url":"https://clinicaltrials.gov/study/NCT04177706","title":"A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Ketamine for the Treatment of Concurrent Opioid Use Disorder and Major Depressive Disorder","has_exemption":false,"start_date":"2020-12-17","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported-late","is_pact":false,"days_late":98},{"registry_id":"NCT04549363","publication_url":"https://clinicaltrials.gov/study/NCT04549363","title":"Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin (GSK2857916)","has_exemption":false,"start_date":"2020-12-21","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04797715","publication_url":"https://clinicaltrials.gov/study/NCT04797715","title":"A Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type","has_exemption":true,"start_date":"2020-12-31","completion_date":"2022-11-21","has_results":false,"results_due":true,"sponsor_name":"Axsome Therapeutics, Inc.","sponsor_slug":"axsome-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04619004","publication_url":"https://clinicaltrials.gov/study/NCT04619004","title":"HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects With Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2021-02-02","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"reported-late","is_pact":false,"days_late":104},{"registry_id":"NCT04852978","publication_url":"https://clinicaltrials.gov/study/NCT04852978","title":"A Phase 2 Randomized, Open-Label, Parallel Group Study to Assess the Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers","has_exemption":false,"start_date":"2021-04-29","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04964609","publication_url":"https://clinicaltrials.gov/study/NCT04964609","title":"Accuracy of Pulse Oximeters With Profound Hypoxia","has_exemption":false,"start_date":"2021-06-16","completion_date":"2022-11-21","has_results":false,"results_due":true,"sponsor_name":"Empatica, Inc.","sponsor_slug":"empatica-inc","status":"overdue","is_pact":false,"days_late":856},{"registry_id":"NCT05053022","publication_url":"https://clinicaltrials.gov/study/NCT05053022","title":"A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo","has_exemption":false,"start_date":"2021-07-29","completion_date":"2022-11-21","has_results":false,"results_due":true,"sponsor_name":"Crown Laboratories, Inc.","sponsor_slug":"crown-laboratories-inc","status":"overdue","is_pact":false,"days_late":856},{"registry_id":"NCT05083260","publication_url":"https://clinicaltrials.gov/study/NCT05083260","title":"A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's Disease (PD) Participants Treated With Carbidopa/Levodopa and NE3107","has_exemption":false,"start_date":"2022-01-04","completion_date":"2022-11-21","has_results":false,"results_due":true,"sponsor_name":"BioVie Inc.","sponsor_slug":"biovie-inc","status":"overdue","is_pact":false,"days_late":856},{"registry_id":"NCT05195528","publication_url":"https://clinicaltrials.gov/study/NCT05195528","title":"A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg Compared to Placebo for Relief of Heartburn in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) After 4 Weeks and to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg for Relief of Heartburn in Subjects With NERD After 6 Months","has_exemption":false,"start_date":"2022-01-17","completion_date":"2022-11-21","has_results":true,"results_due":true,"sponsor_name":"Phathom Pharmaceuticals, Inc.","sponsor_slug":"phathom-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03508440","publication_url":"https://clinicaltrials.gov/study/NCT03508440","title":"Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis","has_exemption":false,"start_date":"2018-01-31","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"reported-late","is_pact":false,"days_late":247},{"registry_id":"NCT03797014","publication_url":"https://clinicaltrials.gov/study/NCT03797014","title":"Efficacy, Safety, and Tolerability of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-HBV Coinfection","has_exemption":false,"start_date":"2019-04-30","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04188834","publication_url":"https://clinicaltrials.gov/study/NCT04188834","title":"Neurophysiological and Behavioral Effects of Sensory Flicker and Electrical Flicker Stimulation","has_exemption":true,"start_date":"2020-01-10","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04264208","publication_url":"https://clinicaltrials.gov/study/NCT04264208","title":"Evaluation of Patients With Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68-Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI","has_exemption":false,"start_date":"2020-02-05","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Andrei Iagaru","sponsor_slug":"andrei-iagaru","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04418427","publication_url":"https://clinicaltrials.gov/study/NCT04418427","title":"A Phase 2, Multi-Center, Randomized, Double-Masked, Active Controlled Study of ADVM-022 (AAV.7m8-aflibercept) in Subjects With Diabetic Macular Edema [INFINITY]","has_exemption":false,"start_date":"2020-05-28","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Adverum Biotechnologies, Inc.","sponsor_slug":"adverum-biotechnologies-inc","status":"reported-late","is_pact":false,"days_late":536},{"registry_id":"NCT04432597","publication_url":"https://clinicaltrials.gov/study/NCT04432597","title":"Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects With HPV Positive Cancers","has_exemption":true,"start_date":"2020-08-11","completion_date":"2022-11-22","has_results":false,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"overdue","is_pact":false,"days_late":124},{"registry_id":"NCT04392167","publication_url":"https://clinicaltrials.gov/study/NCT04392167","title":"Advanced Angle-Resolved Low Coherence Interferometry (a/LCI) Systems for Improved Clinical Utility: An a/LCI-Optical Coherence Tomography (OCT) Pilot Study","has_exemption":false,"start_date":"2020-11-24","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04662359","publication_url":"https://clinicaltrials.gov/study/NCT04662359","title":"Ultrasound to Enhance Treat-to-Target in Rheumatoid Arthritis: A Cross-sectional Study","has_exemption":true,"start_date":"2021-03-03","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04856865","publication_url":"https://clinicaltrials.gov/study/NCT04856865","title":"A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (The Harmony Study)","has_exemption":false,"start_date":"2021-04-20","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Alladapt Immunotherapeutics, Inc.","sponsor_slug":"alladapt-immunotherapeutics-inc","status":"reported-late","is_pact":false,"days_late":141},{"registry_id":"NCT04909593","publication_url":"https://clinicaltrials.gov/study/NCT04909593","title":"Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial: The AIM Study","has_exemption":false,"start_date":"2021-05-24","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported-late","is_pact":false,"days_late":314},{"registry_id":"NCT04900038","publication_url":"https://clinicaltrials.gov/study/NCT04900038","title":"A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults","has_exemption":false,"start_date":"2021-08-18","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05333289","publication_url":"https://clinicaltrials.gov/study/NCT05333289","title":"Phase 1/2, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1020 and mRNA-1030 Candidate Seasonal Influenza Vaccines in Healthy Adults","has_exemption":false,"start_date":"2022-04-06","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05756348","publication_url":"https://clinicaltrials.gov/study/NCT05756348","title":"An Evaluation of the Skin Protection Characteristics of Two Commercially Available Skin Barrier Protectants","has_exemption":false,"start_date":"2022-10-06","completion_date":"2022-11-22","has_results":true,"results_due":true,"sponsor_name":"Medline Industries","sponsor_slug":"medline-industries","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05629455","publication_url":"https://clinicaltrials.gov/study/NCT05629455","title":"CareSuperb COVID-19 Antigen Home Test Usability Study","has_exemption":false,"start_date":"2022-11-17","completion_date":"2022-11-22","has_results":false,"results_due":true,"sponsor_name":"AccessBio, Inc.","sponsor_slug":"accessbio-inc","status":"overdue","is_pact":false,"days_late":855},{"registry_id":"NCT02510261","publication_url":"https://clinicaltrials.gov/study/NCT02510261","title":"A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study","has_exemption":false,"start_date":"2015-07-16","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03993509","publication_url":"https://clinicaltrials.gov/study/NCT03993509","title":"Examining the Mechanisms of Anxiety Regulation Using a Novel, Sham-controlled, fMRI-guided rTMS Protocol and a Translational Laboratory Model of Anxiety","has_exemption":false,"start_date":"2019-10-30","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported-late","is_pact":false,"days_late":315},{"registry_id":"NCT04399837","publication_url":"https://clinicaltrials.gov/study/NCT04399837","title":"Effisayil™ 2: Multi-center, Randomized, Parallel Group, Double Blind, Placebo Controlled, Phase IIb Dose-finding Study to Evaluate Efficacy and Safety of BI 655130 (Spesolimab) Compared to Placebo in Preventing Generalized Pustular Psoriasis (GPP) Flares in Patients With History of GPP.","has_exemption":false,"start_date":"2020-06-04","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04159571","publication_url":"https://clinicaltrials.gov/study/NCT04159571","title":"QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt","has_exemption":false,"start_date":"2020-08-20","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":false,"days_late":127},{"registry_id":"NCT04103749","publication_url":"https://clinicaltrials.gov/study/NCT04103749","title":"Global Prospective Case Series Using a Single-Use Duodenoscope","has_exemption":false,"start_date":"2021-03-22","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05360784","publication_url":"https://clinicaltrials.gov/study/NCT05360784","title":"The Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Preservative-Free Formulation With Lumify® 0.025% in Adult Subjects With Ocular Redness","has_exemption":false,"start_date":"2022-05-13","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"Bausch & Lomb Incorporated","sponsor_slug":"bausch-lomb-incorporated","status":"reported-late","is_pact":false,"days_late":113},{"registry_id":"NCT05412966","publication_url":"https://clinicaltrials.gov/study/NCT05412966","title":"A Feasibility Study of PEAR-002b, a Novel Prescription Digital Therapeutic to Support Unobserved Buprenorphine Initiation and Adherence in Opioid Use Disorder Outpatients","has_exemption":false,"start_date":"2022-11-04","completion_date":"2022-11-23","has_results":false,"results_due":true,"sponsor_name":"Pear Therapeutics, Inc.","sponsor_slug":"pear-therapeutics-inc","status":"overdue","is_pact":false,"days_late":854},{"registry_id":"NCT05006417","publication_url":"https://clinicaltrials.gov/study/NCT05006417","title":"OnabotulinumtoxinA (Botox) Effect on Pain and Function in Recurrent Chronic Exertional Compartment Syndrome: a Pilot Study","has_exemption":false,"start_date":"2022-11-23","completion_date":"2022-11-23","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported-late","is_pact":false,"days_late":210},{"registry_id":"NCT02176863","publication_url":"https://clinicaltrials.gov/study/NCT02176863","title":"A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Participants With Post-Polio Syndrome","has_exemption":true,"start_date":"2014-09-23","completion_date":"2022-11-24","has_results":true,"results_due":true,"sponsor_name":"Instituto Grifols, S.A.","sponsor_slug":"instituto-grifols-sa","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT05190419","publication_url":"https://clinicaltrials.gov/study/NCT05190419","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of Orismilast in Adults With Moderate-to-Severe Plaque-Type Psoriasis","has_exemption":false,"start_date":"2021-12-30","completion_date":"2022-11-24","has_results":true,"results_due":true,"sponsor_name":"UNION therapeutics","sponsor_slug":"union-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04699461","publication_url":"https://clinicaltrials.gov/study/NCT04699461","title":"A Phase 2 Randomized Study of Loncastuximab Tesirine Versus Idelalisib in Patients With Relapsed or Refractory Follicular Lymphoma (LOTIS-6)","has_exemption":false,"start_date":"2021-11-04","completion_date":"2022-11-25","has_results":true,"results_due":true,"sponsor_name":"ADC Therapeutics S.A.","sponsor_slug":"adc-therapeutics-sa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05996588","publication_url":"https://clinicaltrials.gov/study/NCT05996588","title":"Comparison Between Inhalational Anesthetic (Sevoflurane) and Intravenous Anesthetic (Propofol Infusion) for Maintenance of Sedation During Endoscopic Retrograde Cholangiopancreatography","has_exemption":false,"start_date":"2022-01-05","completion_date":"2022-11-25","has_results":false,"results_due":true,"sponsor_name":"Sindh Institute of Urology and Transplantation","sponsor_slug":"sindh-institute-of-urology-and-transplantation","status":"overdue","is_pact":false,"days_late":852},{"registry_id":"NCT01364480","publication_url":"https://clinicaltrials.gov/study/NCT01364480","title":"Microelectrode Brain-Machine Interface for Individuals With Tetraplegia","has_exemption":false,"start_date":"2011-05-01","completion_date":"2022-11-26","has_results":true,"results_due":true,"sponsor_name":"Michael Boninger","sponsor_slug":"michael-boninger","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03405792","publication_url":"https://clinicaltrials.gov/study/NCT03405792","title":"Phase 2, Single Arm, Historically Controlled Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)","has_exemption":false,"start_date":"2018-02-23","completion_date":"2022-11-26","has_results":true,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02513563","publication_url":"https://clinicaltrials.gov/study/NCT02513563","title":"A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer","has_exemption":false,"start_date":"2015-10-13","completion_date":"2022-11-27","has_results":true,"results_due":true,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT03314935","publication_url":"https://clinicaltrials.gov/study/NCT03314935","title":"A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2017-11-21","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03342404","publication_url":"https://clinicaltrials.gov/study/NCT03342404","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Determine the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Adults With Non-Transfusion Dependent Beta (β)-Thalassemia (The BEYOND™ Study)","has_exemption":false,"start_date":"2018-02-05","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04239456","publication_url":"https://clinicaltrials.gov/study/NCT04239456","title":"RehaCom Memory Modules in Moderate-to-severe Traumatic Brain Injury (TBI)","has_exemption":false,"start_date":"2018-12-01","completion_date":"2022-11-28","has_results":false,"results_due":true,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"overdue","is_pact":false,"days_late":849},{"registry_id":"NCT04198701","publication_url":"https://clinicaltrials.gov/study/NCT04198701","title":"Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF","has_exemption":false,"start_date":"2019-12-10","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04230980","publication_url":"https://clinicaltrials.gov/study/NCT04230980","title":"The Use of Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery","has_exemption":false,"start_date":"2020-07-28","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04458922","publication_url":"https://clinicaltrials.gov/study/NCT04458922","title":"A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Chondrosarcoma and Clear Cell Sarcoma","has_exemption":false,"start_date":"2020-10-05","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04534725","publication_url":"https://clinicaltrials.gov/study/NCT04534725","title":"COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.","has_exemption":false,"start_date":"2020-12-17","completion_date":"2022-11-28","has_results":false,"results_due":true,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"overdue","is_pact":false,"days_late":849},{"registry_id":"NCT04465136","publication_url":"https://clinicaltrials.gov/study/NCT04465136","title":"The Effect of Cranial Electrotherapy Stimulation as Adjunctive Therapy on Anxiety Disorder in Elderly: an Open-label, Pilot Study","has_exemption":false,"start_date":"2021-02-19","completion_date":"2022-11-28","has_results":false,"results_due":true,"sponsor_name":"Kaohsiung Veterans General Hospital.","sponsor_slug":"kaohsiung-veterans-general-hospital","status":"overdue","is_pact":false,"days_late":849},{"registry_id":"NCT05002738","publication_url":"https://clinicaltrials.gov/study/NCT05002738","title":"Validation of 24-hour Trough Concentration as a Surrogate for Intensive Pharmacokinetic Measurements for a Combined Oral Contraceptive Pill Containing Desogestrel","has_exemption":false,"start_date":"2021-09-10","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported-late","is_pact":false,"days_late":526},{"registry_id":"NCT05350423","publication_url":"https://clinicaltrials.gov/study/NCT05350423","title":"Use of Urinary Biomarkers to Quantify Degree of Renal, Parenchymal and Urothelial Damage During Ureteroscopy","has_exemption":false,"start_date":"2021-10-22","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04798989","publication_url":"https://clinicaltrials.gov/study/NCT04798989","title":"A Phase 2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CY6463 When Administered to Participants With Alzheimer's Disease and Vascular Pathology","has_exemption":true,"start_date":"2021-11-02","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Tisento Therapeutics","sponsor_slug":"tisento-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05261126","publication_url":"https://clinicaltrials.gov/study/NCT05261126","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia","has_exemption":false,"start_date":"2022-03-10","completion_date":"2022-11-28","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03794583","publication_url":"https://clinicaltrials.gov/study/NCT03794583","title":"An Open-Label Extension Study of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)","has_exemption":false,"start_date":"2018-12-21","completion_date":"2022-11-29","has_results":true,"results_due":true,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04224961","publication_url":"https://clinicaltrials.gov/study/NCT04224961","title":"Moderate Intensity Respiratory Muscle Training (RMT) in ALS","has_exemption":false,"start_date":"2020-01-14","completion_date":"2022-11-29","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04738123","publication_url":"https://clinicaltrials.gov/study/NCT04738123","title":"A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adults With DSM-5 Schizophrenia","has_exemption":true,"start_date":"2021-04-06","completion_date":"2022-11-29","has_results":true,"results_due":true,"sponsor_name":"Karuna Therapeutics","sponsor_slug":"karuna-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05494450","publication_url":"https://clinicaltrials.gov/study/NCT05494450","title":"An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds","has_exemption":false,"start_date":"2022-01-01","completion_date":"2022-11-29","has_results":false,"results_due":true,"sponsor_name":"Molnlycke Health Care AB","sponsor_slug":"molnlycke-health-care-ab","status":"overdue","is_pact":false,"days_late":848},{"registry_id":"NCT05161156","publication_url":"https://clinicaltrials.gov/study/NCT05161156","title":"Multicentre,Randomized,Double-Blind,Double-Dummy,3period,6Seq,Crossover,Active&Placebo,SD PD Study to Evaluate Therapeutic Equivalence of Test Tiotropium Bromide Inh. Powder to Reference SPIRIVA® HANDIHALER in Subjects w/COPD*","has_exemption":false,"start_date":"2022-03-24","completion_date":"2022-11-29","has_results":false,"results_due":true,"sponsor_name":"Phargentis SA","sponsor_slug":"phargentis-sa","status":"overdue","is_pact":false,"days_late":848},{"registry_id":"NCT05368012","publication_url":"https://clinicaltrials.gov/study/NCT05368012","title":"MIDCAB (Mid-Calf Block) for Foot Surgery: A Pilot Study","has_exemption":false,"start_date":"2022-07-21","completion_date":"2022-11-29","has_results":true,"results_due":true,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"reported-late","is_pact":false,"days_late":440},{"registry_id":"NCT05548270","publication_url":"https://clinicaltrials.gov/study/NCT05548270","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion","has_exemption":false,"start_date":"2022-08-23","completion_date":"2022-11-29","has_results":false,"results_due":true,"sponsor_name":"Repurposed Therapeutics, Inc.","sponsor_slug":"repurposed-therapeutics-inc","status":"overdue","is_pact":false,"days_late":848},{"registry_id":"NCT00045968","publication_url":"https://clinicaltrials.gov/study/NCT00045968","title":"A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM)","has_exemption":false,"start_date":"2006-12-31","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Northwest Biotherapeutics","sponsor_slug":"northwest-biotherapeutics","status":"overdue","is_pact":true,"days_late":847},{"registry_id":"NCT02229136","publication_url":"https://clinicaltrials.gov/study/NCT02229136","title":"Evaluation of Miracle Mouthwash (MMW) Plus Hydrocortisone and Prednisolone Mouth Rinse as Prophylaxis for Everolimus-Associated Stomatitis","has_exemption":false,"start_date":"2014-09-04","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"US Oncology Research","sponsor_slug":"us-oncology-research","status":"overdue","is_pact":true,"days_late":847},{"registry_id":"NCT02805595","publication_url":"https://clinicaltrials.gov/study/NCT02805595","title":"A Single Center Clinical Trial to Evaluate the Effect of Sclerotherapy on Fistulas and Sinus Tracts in Adult Patients With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2016-08-31","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported-late","is_pact":true,"days_late":265},{"registry_id":"NCT02862158","publication_url":"https://clinicaltrials.gov/study/NCT02862158","title":"Evaluation of Different Frequency Doubling Technology (FDT) Mobile Devices for Visual Field Assessment","has_exemption":false,"start_date":"2016-08-31","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"overdue","is_pact":true,"days_late":847},{"registry_id":"NCT02464878","publication_url":"https://clinicaltrials.gov/study/NCT02464878","title":"Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant","has_exemption":false,"start_date":"2017-01-31","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03206203","publication_url":"https://clinicaltrials.gov/study/NCT03206203","title":"A Phase II Trial of Atezolizumab (Anti-PDL1) With Carboplatin in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2017-08-29","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03589300","publication_url":"https://clinicaltrials.gov/study/NCT03589300","title":"Persona® TM Tibia Clinical Outcomes Study: Prospective Multicenter Study of the Persona® Trabecular Metal Tibia","has_exemption":false,"start_date":"2018-04-30","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"reported-late","is_pact":false,"days_late":209},{"registry_id":"NCT03258931","publication_url":"https://clinicaltrials.gov/study/NCT03258931","title":"Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-08-15","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04420442","publication_url":"https://clinicaltrials.gov/study/NCT04420442","title":"Influence of Surgical Scar Resection, Followed by Reconstruction With Integra and Split Skin Grafts on Quality of Life, Body Perception, Scar Perception and Stigmatization in Patients With Non-Suicidal Self-Inflicted Scars","has_exemption":false,"start_date":"2018-11-06","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Berufsgenossenschaftliche Unfallklinik Ludwigshafen","sponsor_slug":"berufsgenossenschaftliche-unfallklinik-ludwigshafen","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT03858751","publication_url":"https://clinicaltrials.gov/study/NCT03858751","title":"Pharmacological Activation of Hypoglossal Motor Nucleus for Obstructive Sleep Apnea Aim 2","has_exemption":false,"start_date":"2019-03-01","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":false,"days_late":320},{"registry_id":"NCT05328778","publication_url":"https://clinicaltrials.gov/study/NCT05328778","title":"Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery","has_exemption":false,"start_date":"2019-07-16","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Guangzhou General Hospital of Guangzhou Military Command","sponsor_slug":"guangzhou-general-hospital-of-guangzhou-military-command","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04925232","publication_url":"https://clinicaltrials.gov/study/NCT04925232","title":"Transcranial Magnetic Stimulation for Visual Snow Syndrome: An Open-Label Feasibility Treatment Trial","has_exemption":false,"start_date":"2019-08-01","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT03656666","publication_url":"https://clinicaltrials.gov/study/NCT03656666","title":"The AP-GELP Study: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Phosphodiesterase 4-Inhibitor Apremilast in Female Genital Erosive Lichen Planus","has_exemption":false,"start_date":"2019-09-24","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Oslo University Hospital","sponsor_slug":"oslo-university-hospital","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04020341","publication_url":"https://clinicaltrials.gov/study/NCT04020341","title":"A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)","has_exemption":false,"start_date":"2019-10-17","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03610438","publication_url":"https://clinicaltrials.gov/study/NCT03610438","title":"A Phase IIA Study of Feasibility and Effectiveness of Inotuzumab Ozogamicin (IO) in Adult Patients With B-Cell Acute Lymphoblastic Leukemia With Positive Minimal Residual Disease Before Any Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2019-10-30","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","sponsor_slug":"gruppo-italiano-malattie-ematologiche-delladulto","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT03980184","publication_url":"https://clinicaltrials.gov/study/NCT03980184","title":"The Use of Guanfacine (GUA) (3mg/Day) to Reduce Drug Craving, Improve Cognitive Flexibility and Result in Associated Lower Drug Use in Women With Substance Use Disorder (SUD).","has_exemption":false,"start_date":"2019-11-01","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04285515","publication_url":"https://clinicaltrials.gov/study/NCT04285515","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) or Major Depressive Disorder","has_exemption":false,"start_date":"2020-02-27","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"reported-late","is_pact":false,"days_late":460},{"registry_id":"NCT04372706","publication_url":"https://clinicaltrials.gov/study/NCT04372706","title":"Phase 1/2 Study of RTX-240 Monotherapy and in Combination With Pembrolizumab","has_exemption":false,"start_date":"2020-05-06","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Rubius Therapeutics","sponsor_slug":"rubius-therapeutics","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04398446","publication_url":"https://clinicaltrials.gov/study/NCT04398446","title":"Coala-T-CBD Study: A Study of the Effect of Hemp-CBD on the Severity and Duration of Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Neurotoxic Chemotherapy for Non-Metastatic Breast, Uterine, Pancreatic, and Colorectal Cancer and All Stages of Ovarian Cancer","has_exemption":false,"start_date":"2020-05-27","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Main Line Health","sponsor_slug":"main-line-health","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04213079","publication_url":"https://clinicaltrials.gov/study/NCT04213079","title":"Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage","has_exemption":false,"start_date":"2020-06-15","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04191616","publication_url":"https://clinicaltrials.gov/study/NCT04191616","title":"An Open-label, Phase 2 Study Treating Subjects With First or Second Relapse of Multiple Myeloma With Carfilzomib, Pomalidomide, and Dexamethasone (KPd)","has_exemption":false,"start_date":"2020-08-06","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04583358","publication_url":"https://clinicaltrials.gov/study/NCT04583358","title":"A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects With Moderate to Severe Ulcerative Colitis (LOMBARD)","has_exemption":false,"start_date":"2020-08-26","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Applied Molecular Transport","sponsor_slug":"applied-molecular-transport","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04420195","publication_url":"https://clinicaltrials.gov/study/NCT04420195","title":"Pilot Study Comparing Early Conversion to Extended-Release Tacrolimus (ENVARSUS XR) to Immediate-Release Tacrolimus in Lung Transplant Recipients","has_exemption":false,"start_date":"2020-10-23","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04601077","publication_url":"https://clinicaltrials.gov/study/NCT04601077","title":"Pilot Study: The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin","has_exemption":false,"start_date":"2020-11-01","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Nitric Oxide Innovations LLC","sponsor_slug":"nitric-oxide-innovations-llc","status":"reported-late","is_pact":false,"days_late":216},{"registry_id":"NCT04519671","publication_url":"https://clinicaltrials.gov/study/NCT04519671","title":"A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease","has_exemption":false,"start_date":"2020-11-19","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Amy Lightner","sponsor_slug":"amy-lightner","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT03443700","publication_url":"https://clinicaltrials.gov/study/NCT03443700","title":"Randomized Controlled Trial on Rehabilitation Training With a Robotic Anthropomorphic Exoskeleton in Patients With Motor Incomplete Spinal Cord Injury: Clinical Outcomes and Cortical Plasticity Indicators","has_exemption":false,"start_date":"2020-12-10","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Azienda Usl di Bologna","sponsor_slug":"azienda-usl-di-bologna","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05012683","publication_url":"https://clinicaltrials.gov/study/NCT05012683","title":"To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees","has_exemption":false,"start_date":"2021-01-05","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Point Designs","sponsor_slug":"point-designs","status":"reported-late","is_pact":false,"days_late":28},{"registry_id":"NCT04734379","publication_url":"https://clinicaltrials.gov/study/NCT04734379","title":"A Phase 2a Open-Label Preliminary Safety, Tolerability, and Biomarker Study of Oral Fasudil in Patients With the 4-Repeat Tauopathies of Progressive Supranuclear Palsy-Richardson Syndrome or Corticobasal Syndrome.","has_exemption":false,"start_date":"2021-01-22","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Woolsey Pharmaceuticals","sponsor_slug":"woolsey-pharmaceuticals","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04347161","publication_url":"https://clinicaltrials.gov/study/NCT04347161","title":"Implementation Strategies for Monitoring Adherence in Real Time","has_exemption":false,"start_date":"2021-02-22","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"reported-late","is_pact":false,"days_late":9},{"registry_id":"NCT04975243","publication_url":"https://clinicaltrials.gov/study/NCT04975243","title":"Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro™/GentleMax Pro Plus™","has_exemption":false,"start_date":"2021-03-19","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Candela Corporation","sponsor_slug":"candela-corporation","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04850664","publication_url":"https://clinicaltrials.gov/study/NCT04850664","title":"Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder","has_exemption":false,"start_date":"2021-03-26","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Evon Medics LLC","sponsor_slug":"evon-medics-llc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04750577","publication_url":"https://clinicaltrials.gov/study/NCT04750577","title":"Randomised, Double-blind (Within Dose Groups), Placebo-controlled and Parallel Group Trial to Investigate the Effects of Different Doses of Oral BI 685509 Given Over 20 Weeks on UACR Reduction in Patients With Diabetic Kidney Disease","has_exemption":true,"start_date":"2021-04-27","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04615949","publication_url":"https://clinicaltrials.gov/study/NCT04615949","title":"Study to Evaluate the Efficacy and Safety of CardiolRx™ in Patients With COVID-19 and Cardiovascular Disease or Risk Factors A Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2021-04-30","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Cardiol Therapeutics Inc.","sponsor_slug":"cardiol-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":571},{"registry_id":"NCT04855721","publication_url":"https://clinicaltrials.gov/study/NCT04855721","title":"A Phase II, Multicenter, Double-blind, Double-dummy, Placebo Controlled, Randomized Study to Evaluate the Efficacy and Safety of AUR101 in Patients With Moderate-to-Severe Psoriasis (INDUS-3)","has_exemption":false,"start_date":"2021-05-04","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Aurigene Discovery Technologies Limited","sponsor_slug":"aurigene-discovery-technologies-limited","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04786470","publication_url":"https://clinicaltrials.gov/study/NCT04786470","title":"Transversus Abdominis Plane Catheter Following Kidney Transplantation","has_exemption":false,"start_date":"2021-05-31","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Western University, Canada","sponsor_slug":"western-university-canada","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04909723","publication_url":"https://clinicaltrials.gov/study/NCT04909723","title":"Phase 1-2a Safety, Tolerability, and Pharmacodynamics Controlled Study of NOV-001 in Healthy Volunteers and Patients With Enteric Hyperoxaluria","has_exemption":false,"start_date":"2021-06-02","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Novome Biotechnologies Inc","sponsor_slug":"novome-biotechnologies-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04766229","publication_url":"https://clinicaltrials.gov/study/NCT04766229","title":"A Multimodal Technology-assisted Intervention for the Management of Menopause After Cancer: The Menopause After Cancer Study","has_exemption":false,"start_date":"2021-06-21","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"University College Dublin","sponsor_slug":"university-college-dublin","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05036343","publication_url":"https://clinicaltrials.gov/study/NCT05036343","title":"Smart Insulin Pens: A Randomized, Crossover Prospective Interventional Pilot Study Assessing the Effect on Glycemic Control and Diabetes Related Burdens","has_exemption":false,"start_date":"2021-09-14","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05053880","publication_url":"https://clinicaltrials.gov/study/NCT05053880","title":"A Phase 1b/2a Study of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme","has_exemption":false,"start_date":"2021-09-22","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Accendatech USA Inc.","sponsor_slug":"accendatech-usa-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05418829","publication_url":"https://clinicaltrials.gov/study/NCT05418829","title":"An Open-Label Study to Evaluate the Long-Term Safety and Pharmacodynamic Efficacy of AT-007 in Adult Subjects With Classic Galactosemia (CG)","has_exemption":false,"start_date":"2021-10-01","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Applied Therapeutics, Inc.","sponsor_slug":"applied-therapeutics-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05069415","publication_url":"https://clinicaltrials.gov/study/NCT05069415","title":"Visual Performance and Patient Satisfaction With A New Monofocal Intraocular Lens","has_exemption":false,"start_date":"2021-10-04","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Carolina Eyecare Physicians, LLC","sponsor_slug":"carolina-eyecare-physicians-llc","status":"reported-late","is_pact":false,"days_late":50},{"registry_id":"NCT05044234","publication_url":"https://clinicaltrials.gov/study/NCT05044234","title":"A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Cedirogant (ABBV-157) in Adult Subjects With Moderate to Severe Psoriasis","has_exemption":false,"start_date":"2021-11-16","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05154682","publication_url":"https://clinicaltrials.gov/study/NCT05154682","title":"Multi-Modal Pain Management After Outpatient Orthopaedic Surgery: A Prospective Randomized Trial","has_exemption":false,"start_date":"2021-11-30","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Rothman Institute Orthopaedics","sponsor_slug":"rothman-institute-orthopaedics","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05525026","publication_url":"https://clinicaltrials.gov/study/NCT05525026","title":"Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling","has_exemption":false,"start_date":"2021-12-08","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"BTL Industries Ltd.","sponsor_slug":"btl-industries-ltd","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT04843579","publication_url":"https://clinicaltrials.gov/study/NCT04843579","title":"A Phase 2, Open-Label, Single-Arm Study of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-12-29","completion_date":"2022-11-30","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05219578","publication_url":"https://clinicaltrials.gov/study/NCT05219578","title":"A Phase 1/2 Study of RTX-224 for the Treatment of Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-01-12","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Rubius Therapeutics","sponsor_slug":"rubius-therapeutics","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05200390","publication_url":"https://clinicaltrials.gov/study/NCT05200390","title":"Closing the Gap in Health Disparities and Improving Health Outcomes: Evaluation of a Single Center Expansion of Continuous Glucose Monitor Access in Patients With Type 2 Diabetes","has_exemption":false,"start_date":"2022-01-24","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Chieh Chen","sponsor_slug":"chieh-chen","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05084183","publication_url":"https://clinicaltrials.gov/study/NCT05084183","title":"An Adaptive, Randomized, Controlled Trial Evaluating the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag® Used as Standard of Care in the Treatment of Adult and Pediatric Partial Thickness Burns.","has_exemption":false,"start_date":"2022-02-02","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Stedical Scientific, Inc.","sponsor_slug":"stedical-scientific-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05165992","publication_url":"https://clinicaltrials.gov/study/NCT05165992","title":"Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 (Ventanyl Trial)","has_exemption":false,"start_date":"2022-02-28","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Hamad Medical Corporation","sponsor_slug":"hamad-medical-corporation","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05293665","publication_url":"https://clinicaltrials.gov/study/NCT05293665","title":"A Phase 3 Multi-Center International, Randomized, Active-Controlled Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine","has_exemption":false,"start_date":"2022-03-16","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Vaxxinity, Inc.","sponsor_slug":"vaxxinity-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05371535","publication_url":"https://clinicaltrials.gov/study/NCT05371535","title":"A Prospective, Randomized, Multi-center, Parallel Controlled Trial Evaluating the Efficacy and Safety of MatrixOssTM Bone Graft in Bone Defect Repair Caused by Tooth Extraction","has_exemption":false,"start_date":"2022-05-30","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Collagen Matrix","sponsor_slug":"collagen-matrix","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT05486325","publication_url":"https://clinicaltrials.gov/study/NCT05486325","title":"Pilot Study of the Endolumik Gastric Calibration Tube for Bariatric Surgery","has_exemption":false,"start_date":"2022-08-31","completion_date":"2022-11-30","has_results":false,"results_due":true,"sponsor_name":"Endolumik, Inc","sponsor_slug":"endolumik-inc","status":"overdue","is_pact":false,"days_late":847},{"registry_id":"NCT01674140","publication_url":"https://clinicaltrials.gov/study/NCT01674140","title":"Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer","has_exemption":false,"start_date":"2013-09-12","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02079740","publication_url":"https://clinicaltrials.gov/study/NCT02079740","title":"An Open Label, Two-Part, Phase Ib/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor Trametinib and the BCL2-Family Inhibitor Navitoclax (ABT-263) in Combination in Subjects With KRAS or NRAS Mutation-Positive Advanced Solid Tumors","has_exemption":false,"start_date":"2014-03-26","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":258},{"registry_id":"NCT02520063","publication_url":"https://clinicaltrials.gov/study/NCT02520063","title":"A Phase I/II Study of Preoperative (Neoadjuvant) Combination of Letrozole (Femara), Everolimus (Afinitor), and TRC105 in Postmenopausal Women With Newly Diagnosed Local or Locally Advanced Potentially Resectable Hormone-Receptor Positive and Her2 Negative Breast Cancer","has_exemption":false,"start_date":"2015-02-01","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT05600491","publication_url":"https://clinicaltrials.gov/study/NCT05600491","title":"A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme","has_exemption":false,"start_date":"2015-11-08","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Sun Yat-sen University","sponsor_slug":"sun-yat-sen-university","status":"overdue","is_pact":true,"days_late":846},{"registry_id":"NCT03034538","publication_url":"https://clinicaltrials.gov/study/NCT03034538","title":"An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease","has_exemption":false,"start_date":"2016-04-08","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"The Cooper Health System","sponsor_slug":"the-cooper-health-system","status":"overdue","is_pact":true,"days_late":846},{"registry_id":"NCT02829723","publication_url":"https://clinicaltrials.gov/study/NCT02829723","title":"A Phase I/II, Open-label, Multi-center Study of the Safety and Efficacy of BLZ945 as Single Agent and in Combination With PDR001 in Adults Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2016-10-21","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03130946","publication_url":"https://clinicaltrials.gov/study/NCT03130946","title":"Comparison of the Accuracy and Safety of Biopsy in Suspicious Axillary Lymph Nodes With a Crypo-assisted Stick Freeze Biopsy Device or Fine Needle Aspiration","has_exemption":false,"start_date":"2017-05-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Peking University People's Hospital","sponsor_slug":"peking-university-peoples-hospital","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT03176277","publication_url":"https://clinicaltrials.gov/study/NCT03176277","title":"A Phase I/II Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Efficacy of ONO-7475 in Patients With Acute Leukemias or Myelodysplastic Syndromes","has_exemption":false,"start_date":"2017-06-26","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03316859","publication_url":"https://clinicaltrials.gov/study/NCT03316859","title":"A Prospective Randomized, Double-Blind Study to Evaluate the Addition of Naloxegol to the Pre-Op Regimen of the Cardiac Surgery Patient and Its Effect on Opioid-Induced Constipation","has_exemption":false,"start_date":"2017-11-06","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"TriHealth Inc.","sponsor_slug":"trihealth-inc","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT03421275","publication_url":"https://clinicaltrials.gov/study/NCT03421275","title":"Intranasal Fentanyl and Esketamine for Treatment of Acute Pain in Minor Trauma Patients","has_exemption":false,"start_date":"2017-12-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Anna Meuronen, MD","sponsor_slug":"anna-meuronen-md","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT04361071","publication_url":"https://clinicaltrials.gov/study/NCT04361071","title":"Clinical Study of Stent Versus Direct Atherectomy to Treat Iliac Artery Occlusive Diseases","has_exemption":false,"start_date":"2018-08-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Xuanwu Hospital, Beijing","sponsor_slug":"xuanwu-hospital-beijing","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT04112407","publication_url":"https://clinicaltrials.gov/study/NCT04112407","title":"The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty; a Pilot Study","has_exemption":false,"start_date":"2019-01-10","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT03971071","publication_url":"https://clinicaltrials.gov/study/NCT03971071","title":"A Phase 4, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache","has_exemption":false,"start_date":"2019-10-07","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04221763","publication_url":"https://clinicaltrials.gov/study/NCT04221763","title":"Evaluation of Mechanisms and Innovations in Cardiac Resynchronization Therapy","has_exemption":false,"start_date":"2019-10-15","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"reported-late","is_pact":false,"days_late":14},{"registry_id":"NCT04172961","publication_url":"https://clinicaltrials.gov/study/NCT04172961","title":"A Phase 4 Study to Assess the Clinical Efficacy of Nanomicellular Cyclosporine 0.09% Versus Lifitegrast 5.0% for Central Corneal Stain Clearing Over 90 Days","has_exemption":false,"start_date":"2020-02-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Toyos Clinic","sponsor_slug":"toyos-clinic","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT04187144","publication_url":"https://clinicaltrials.gov/study/NCT04187144","title":"A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)","has_exemption":false,"start_date":"2020-04-23","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04292119","publication_url":"https://clinicaltrials.gov/study/NCT04292119","title":"A Phase IB/II Study of Lorlatinib Combinations in Anaplastic Lymphoma Kinase-Rearranged Lung Cancer","has_exemption":false,"start_date":"2020-05-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT05360433","publication_url":"https://clinicaltrials.gov/study/NCT05360433","title":"Impact of Reduced Initial Prescription Size on Opioid Consumption in Postoperative Pain Management for Scheduled Cesarean Deliveries","has_exemption":false,"start_date":"2020-11-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT04580277","publication_url":"https://clinicaltrials.gov/study/NCT04580277","title":"A Single Center Open-Label Prospective Study Of Oral Tofacitinib In Patients With Chronic Pouchitis","has_exemption":false,"start_date":"2021-01-25","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04621786","publication_url":"https://clinicaltrials.gov/study/NCT04621786","title":"Electroconvulsive Therapy Amplitude Titration for Improved Clinical Outcomes in Late Life Depression","has_exemption":false,"start_date":"2021-03-01","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05081011","publication_url":"https://clinicaltrials.gov/study/NCT05081011","title":"Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial","has_exemption":false,"start_date":"2021-03-24","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05050448","publication_url":"https://clinicaltrials.gov/study/NCT05050448","title":"Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for Knee Pain Related to Osteoarthritis","has_exemption":false,"start_date":"2021-08-01","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"ZetrOZ, Inc.","sponsor_slug":"zetroz-inc","status":"reported-late","is_pact":false,"days_late":105},{"registry_id":"NCT05017480","publication_url":"https://clinicaltrials.gov/study/NCT05017480","title":"A Double-blind, Multi-center, Randomized Controlled Clinical Study to Evaluate the Efficacy and Safety of CBP-201 in Chinese Subjects With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2021-08-31","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Connect Biopharm LLC","sponsor_slug":"connect-biopharm-llc","status":"reported-late","is_pact":false,"days_late":62},{"registry_id":"NCT05034939","publication_url":"https://clinicaltrials.gov/study/NCT05034939","title":"FLEX Vessel Prep Prior to the Treatment of Obstructive Lesions in the Native Arteriovenous Dialysis Fistulae","has_exemption":false,"start_date":"2021-09-02","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"VentureMed Group Inc.","sponsor_slug":"venturemed-group-inc","status":"reported-late","is_pact":false,"days_late":482},{"registry_id":"NCT05152966","publication_url":"https://clinicaltrials.gov/study/NCT05152966","title":"PersAFOne II(Pronounced Per-'Se-fa-nē 2); Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2021-09-16","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported-late","is_pact":false,"days_late":38},{"registry_id":"NCT05117632","publication_url":"https://clinicaltrials.gov/study/NCT05117632","title":"An Open-label Study of ALTO-100 in Adults With Major Depressive Disorder and/or Post-traumatic Stress Disorder","has_exemption":true,"start_date":"2021-12-20","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Alto Neuroscience","sponsor_slug":"alto-neuroscience","status":"reported-late","is_pact":false,"days_late":23},{"registry_id":"NCT04298177","publication_url":"https://clinicaltrials.gov/study/NCT04298177","title":"Personalized Atrial Fibrillation Ablation With the QDOT Catheter - The QDOT-by-LAW Trial","has_exemption":false,"start_date":"2022-03-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Antonio Berruezo, MD, PhD","sponsor_slug":"antonio-berruezo-md-phd","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT05393895","publication_url":"https://clinicaltrials.gov/study/NCT05393895","title":"A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Safety of CSF-1 in Presbyopic Subjects","has_exemption":false,"start_date":"2022-04-22","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Orasis Pharmaceuticals Ltd.","sponsor_slug":"orasis-pharmaceuticals-ltd","status":"reported-late","is_pact":false,"days_late":334},{"registry_id":"NCT05209360","publication_url":"https://clinicaltrials.gov/study/NCT05209360","title":"Heel Wedges and Carbon Fiber Custom Dynamic Orthoses to Control Knee Biomechanics","has_exemption":false,"start_date":"2022-05-09","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04009408","publication_url":"https://clinicaltrials.gov/study/NCT04009408","title":"Interventional Study of Expiratory Muscle Strength Training as a Treatment in Neuromuscular Disorders","has_exemption":false,"start_date":"2022-05-31","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"University of Calgary","sponsor_slug":"university-of-calgary","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT05397795","publication_url":"https://clinicaltrials.gov/study/NCT05397795","title":"COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES","has_exemption":false,"start_date":"2022-06-01","completion_date":"2022-12-01","has_results":false,"results_due":true,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"overdue","is_pact":false,"days_late":846},{"registry_id":"NCT05734846","publication_url":"https://clinicaltrials.gov/study/NCT05734846","title":"Biofinity Multifocal Contact Lenses Fitting Methods Comparison","has_exemption":false,"start_date":"2022-10-11","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05554640","publication_url":"https://clinicaltrials.gov/study/NCT05554640","title":"Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses","has_exemption":false,"start_date":"2022-10-24","completion_date":"2022-12-01","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03674047","publication_url":"https://clinicaltrials.gov/study/NCT03674047","title":"A Phase II Study of Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)","has_exemption":false,"start_date":"2019-04-19","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":false,"days_late":807},{"registry_id":"NCT03827291","publication_url":"https://clinicaltrials.gov/study/NCT03827291","title":"Quantitative Observational Comparative Effectiveness of Quadratus Lumborum (QL) Block With Liposomal Bupivacaine (Exparel®) Versus Thoracic Epidural Analgesia in Patients Undergoing Laparoscopic Colectomy.","has_exemption":false,"start_date":"2019-10-31","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04165577","publication_url":"https://clinicaltrials.gov/study/NCT04165577","title":"Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study","has_exemption":false,"start_date":"2019-11-15","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Butler Hospital","sponsor_slug":"butler-hospital","status":"reported-late","is_pact":false,"days_late":86},{"registry_id":"NCT04435431","publication_url":"https://clinicaltrials.gov/study/NCT04435431","title":"A Randomized, Double-blind, Placebo-controlled Phase IIB Study Evaluating the Efficacy of Mesdopetam on Daily ON-time Without Troublesome Dyskinesia in Patients With Parkinson's Disease","has_exemption":false,"start_date":"2020-10-29","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Integrative Research Laboratories AB","sponsor_slug":"integrative-research-laboratories-ab","status":"reported-late","is_pact":false,"days_late":37},{"registry_id":"NCT04586153","publication_url":"https://clinicaltrials.gov/study/NCT04586153","title":"A Multicenter, Seamless, Randomized, Third-Party-Blind, Clinical Trial to Evaluate the Safety and Efficacy of Meplazumab in Addition to Standard of Care for the Treatment of COVID-19 in Hospitalized Adults","has_exemption":false,"start_date":"2021-02-15","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd","sponsor_slug":"jiangsu-pacific-meinuoke-bio-pharmaceutical-co-ltd","status":"overdue","is_pact":false,"days_late":845},{"registry_id":"NCT04781647","publication_url":"https://clinicaltrials.gov/study/NCT04781647","title":"A Randomized Phase 2a, Multicenter, Open-label Study Evaluating ABI-H0731-Containing Regimens in Patients With Chronic Hepatitis B","has_exemption":false,"start_date":"2021-02-18","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Assembly Biosciences","sponsor_slug":"assembly-biosciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04842604","publication_url":"https://clinicaltrials.gov/study/NCT04842604","title":"A MULTI-CENTER CONTINUATION STUDY EVALUATING AZACITIDINE WITH OR WITHOUT GLASDEGIB (PF-04449913) IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROME OR CHRONIC MYELOMONOCYTIC LEUKEMIA","has_exemption":false,"start_date":"2021-05-17","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05100199","publication_url":"https://clinicaltrials.gov/study/NCT05100199","title":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of OnabotulinumtoxinA X for the Treatment of Moderate to Severe Glabellar Lines","has_exemption":true,"start_date":"2021-10-06","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05092828","publication_url":"https://clinicaltrials.gov/study/NCT05092828","title":"Does Intrathecal Morphine Affect Outcomes in Spine Deformity Surgery: A Prospective, Randomized Clinical Controlled Trial","has_exemption":false,"start_date":"2021-12-01","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Sonoran Spine Research and Education Foundation","sponsor_slug":"sonoran-spine-research-and-education-foundation","status":"overdue","is_pact":false,"days_late":845},{"registry_id":"NCT05033964","publication_url":"https://clinicaltrials.gov/study/NCT05033964","title":"The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions","has_exemption":false,"start_date":"2021-12-15","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Elixir Medical Corporation","sponsor_slug":"elixir-medical-corporation","status":"overdue","is_pact":false,"days_late":845},{"registry_id":"NCT05227898","publication_url":"https://clinicaltrials.gov/study/NCT05227898","title":"Two-arm, Double-blind, Randomized Controlled Trial to Compare Efficacy of Two Digital Software Medical Devices as Interventions for Physical and Mental Health in Patients With Stage I-III Cancer","has_exemption":false,"start_date":"2022-03-10","completion_date":"2022-12-02","has_results":false,"results_due":true,"sponsor_name":"Blue Note Therapeutics","sponsor_slug":"blue-note-therapeutics","status":"overdue","is_pact":false,"days_late":845},{"registry_id":"NCT04982029","publication_url":"https://clinicaltrials.gov/study/NCT04982029","title":"Cannabidiol on reward-and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder: A Double-blind, Placebo-controlled, Cross-over Trial","has_exemption":false,"start_date":"2022-04-14","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05573763","publication_url":"https://clinicaltrials.gov/study/NCT05573763","title":"Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022","has_exemption":false,"start_date":"2022-11-14","completion_date":"2022-12-02","has_results":true,"results_due":true,"sponsor_name":"Fisher and Paykel Healthcare","sponsor_slug":"fisher-and-paykel-healthcare","status":"reported-late","is_pact":false,"days_late":296},{"registry_id":"NCT04580160","publication_url":"https://clinicaltrials.gov/study/NCT04580160","title":"Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System","has_exemption":false,"start_date":"2020-11-30","completion_date":"2022-12-03","has_results":true,"results_due":true,"sponsor_name":"Vesper Medical, Inc.","sponsor_slug":"vesper-medical-inc","status":"reported-late","is_pact":false,"days_late":276},{"registry_id":"NCT05203744","publication_url":"https://clinicaltrials.gov/study/NCT05203744","title":"Safety, Tolerability and Pharmacokinetics of Tafenoquine After Weekly and Escalating Monthly Doses of Tafenoquine in Healthy Vietnamese Volunteers","has_exemption":false,"start_date":"2022-05-10","completion_date":"2022-12-03","has_results":false,"results_due":true,"sponsor_name":"Naval Medical Research Center","sponsor_slug":"naval-medical-research-center","status":"overdue","is_pact":false,"days_late":844},{"registry_id":"NCT03440047","publication_url":"https://clinicaltrials.gov/study/NCT03440047","title":"Minimal Risk Registry of Endoscopic Image and Pathology Correlation Using Fujifilm 7000 Blue Light Imaging System With 4 Light-emitting Diode (LED) Multi Light Technology","has_exemption":false,"start_date":"2017-08-28","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03600350","publication_url":"https://clinicaltrials.gov/study/NCT03600350","title":"Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP) and Nivolumab in Patients With Non-Metastatic, PSA-Recurrent Prostate Cancer","has_exemption":false,"start_date":"2018-09-10","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03632720","publication_url":"https://clinicaltrials.gov/study/NCT03632720","title":"Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Using a 1+1 Schedule in a National Immunization Schedule Having a Meningococcal Group B Vaccine as Standard of Care","has_exemption":false,"start_date":"2018-10-10","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03417882","publication_url":"https://clinicaltrials.gov/study/NCT03417882","title":"A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects With Non-Small Cell Lung Cancer With High PD-L1 Expression","has_exemption":false,"start_date":"2019-01-03","completion_date":"2022-12-05","has_results":false,"results_due":true,"sponsor_name":"BrightPath Biotherapeutics","sponsor_slug":"brightpath-biotherapeutics","status":"overdue","is_pact":false,"days_late":842},{"registry_id":"NCT04186871","publication_url":"https://clinicaltrials.gov/study/NCT04186871","title":"A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Branebrutinib Treatment in Subjects With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Subjects With Active Rheumatoid Arthritis","has_exemption":false,"start_date":"2020-01-07","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04403763","publication_url":"https://clinicaltrials.gov/study/NCT04403763","title":"A First-in-Human, Phase 1/2, Dose-ascending, Multicenter, Masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AGN-241622 in Healthy Participants and Participants With Presbyopia (Stage 1 and Stage 2) and Efficacy in Participants With Presbyopia (Stage 2)","has_exemption":false,"start_date":"2020-07-27","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03959982","publication_url":"https://clinicaltrials.gov/study/NCT03959982","title":"The Effect of Heated, Humidified High-flow Air in COPD Patients With Chronic Bronchitis","has_exemption":false,"start_date":"2021-02-24","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Spyridon Fortis","sponsor_slug":"spyridon-fortis","status":"reported-late","is_pact":false,"days_late":224},{"registry_id":"NCT04953728","publication_url":"https://clinicaltrials.gov/study/NCT04953728","title":"TEA for Study Participants With IBS-C Optimization of TEA Modalities for Treatment of IBS-C: A Phase 1 25 Study Participant Clinical Trial of Transcutaneous Electrical Acustimulation (TEA) in Study Participants With IBS-C","has_exemption":false,"start_date":"2021-07-01","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04937088","publication_url":"https://clinicaltrials.gov/study/NCT04937088","title":"Outpatient, Liquid Aspirin to Reduce COVID-19 Hospitalizations","has_exemption":false,"start_date":"2021-12-06","completion_date":"2022-12-05","has_results":false,"results_due":true,"sponsor_name":"Louisiana State University Health Sciences Center in New Orleans","sponsor_slug":"louisiana-state-university-health-sciences-center-in-new-orleans","status":"overdue","is_pact":false,"days_late":842},{"registry_id":"NCT05688657","publication_url":"https://clinicaltrials.gov/study/NCT05688657","title":"Clinical Evaluation of Clariti Monthly Toric and Clariti 1 Day Toric","has_exemption":false,"start_date":"2022-10-22","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05741450","publication_url":"https://clinicaltrials.gov/study/NCT05741450","title":"A Clinical Comparison of Two Soft Contact Lenses (Iteration Under Umbrella Protocol C19-678)","has_exemption":false,"start_date":"2022-11-24","completion_date":"2022-12-05","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02555189","publication_url":"https://clinicaltrials.gov/study/NCT02555189","title":"Phase IB/II Study of Enzalutamide With Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression","has_exemption":false,"start_date":"2015-12-01","completion_date":"2022-12-06","has_results":false,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"reported-late","is_pact":true,"days_late":659},{"registry_id":"NCT03173534","publication_url":"https://clinicaltrials.gov/study/NCT03173534","title":"WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement","has_exemption":false,"start_date":"2017-12-15","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"Samir Kapadia","sponsor_slug":"samir-kapadia","status":"reported-late","is_pact":false,"days_late":36},{"registry_id":"NCT06385483","publication_url":"https://clinicaltrials.gov/study/NCT06385483","title":"MATCH Treatment Subprotocol A: Phase II Trial of Afatinib in Patients With Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard Treatment","has_exemption":false,"start_date":"2018-02-28","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":348},{"registry_id":"NCT03781388","publication_url":"https://clinicaltrials.gov/study/NCT03781388","title":"ED90 for Hyperbaric Bupivacaine in Spinal Anesthesia for Cesarean Delivery in Super Obese Parturients","has_exemption":false,"start_date":"2019-05-01","completion_date":"2022-12-06","has_results":false,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04187053","publication_url":"https://clinicaltrials.gov/study/NCT04187053","title":"Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical Treatment of Peri-implant Disease","has_exemption":false,"start_date":"2020-02-14","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04188574","publication_url":"https://clinicaltrials.gov/study/NCT04188574","title":"A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects With Distal Subungual Onychomycosis (DSO) of the Toenail","has_exemption":true,"start_date":"2021-03-22","completion_date":"2022-12-06","has_results":false,"results_due":true,"sponsor_name":"Blueberry Therapeutics","sponsor_slug":"blueberry-therapeutics","status":"overdue","is_pact":false,"days_late":110},{"registry_id":"NCT03951064","publication_url":"https://clinicaltrials.gov/study/NCT03951064","title":"Effect of Esophageal Pressure Measurement to Determine Optimal Positive End-expiratory Pressure Compared to Usual Care in Obese Patients Receiving Mechanical Ventilation","has_exemption":false,"start_date":"2021-03-31","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported-late","is_pact":false,"days_late":104},{"registry_id":"NCT04969939","publication_url":"https://clinicaltrials.gov/study/NCT04969939","title":"Investigation of Efficacy and Safety of NNC0165-1875 as add-on to Semaglutide for Weight Management in Subjects With Obesity","has_exemption":true,"start_date":"2021-07-15","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05131451","publication_url":"https://clinicaltrials.gov/study/NCT05131451","title":"Autonomous AI for Diabetic Retinopathy Screening in Youth (AI-DR): A Randomized Control Trial","has_exemption":false,"start_date":"2021-11-24","completion_date":"2022-12-06","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03907969","publication_url":"https://clinicaltrials.gov/study/NCT03907969","title":"A Phase I/IIa, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD7648 Monotherapy or in Combination With Either Cytotoxic Chemotherapies or Novel Anti-Cancer Agents in Patients With Advanced Malignancies","has_exemption":false,"start_date":"2019-10-09","completion_date":"2022-12-07","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04718961","publication_url":"https://clinicaltrials.gov/study/NCT04718961","title":"A Phase 2a/2b Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in Adult Women With Intrahepatic Cholestasis of Pregnancy and Elevated Serum Bile Acid Concentrations (OHANA).","has_exemption":false,"start_date":"2021-01-04","completion_date":"2022-12-07","has_results":true,"results_due":true,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07090044","publication_url":"https://clinicaltrials.gov/study/NCT07090044","title":"Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period","has_exemption":false,"start_date":"2021-08-20","completion_date":"2022-12-07","has_results":false,"results_due":true,"sponsor_name":"Retina Research Institute, LLC","sponsor_slug":"retina-research-institute-llc","status":"overdue","is_pact":false,"days_late":840},{"registry_id":"NCT04822467","publication_url":"https://clinicaltrials.gov/study/NCT04822467","title":"SQ53 Disinfectant Wipes for Prevention of Catheter Related Blood Stream Infection in Patients Receiving Home Parenteral Nutrition: A Single Blind Randomized Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2021-12-10","completion_date":"2022-12-07","has_results":true,"results_due":true,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05501860","publication_url":"https://clinicaltrials.gov/study/NCT05501860","title":"A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Evaluation of the Ocular Safety of Articaine Sterile Topical Ophthalmic Solution","has_exemption":false,"start_date":"2022-07-30","completion_date":"2022-12-07","has_results":true,"results_due":true,"sponsor_name":"American Genomics, LLC","sponsor_slug":"american-genomics-llc","status":"reported-late","is_pact":false,"days_late":138},{"registry_id":"NCT05498298","publication_url":"https://clinicaltrials.gov/study/NCT05498298","title":"A Cross-sectional, Interventional, Exploratory Clinical Study to Investigate the Reliability of Fetal Heart Rate and Maternal Heart Rate Signals Extracted From Biopotential Data","has_exemption":false,"start_date":"2022-08-03","completion_date":"2022-12-07","has_results":false,"results_due":true,"sponsor_name":"Bloom Technologies","sponsor_slug":"bloom-technologies","status":"overdue","is_pact":false,"days_late":840},{"registry_id":"NCT05674136","publication_url":"https://clinicaltrials.gov/study/NCT05674136","title":"Clinical Equivalence of Masimo INVSENSOR00061 to RD SET Neo","has_exemption":false,"start_date":"2022-11-18","completion_date":"2022-12-07","has_results":true,"results_due":true,"sponsor_name":"Masimo Corporation","sponsor_slug":"masimo-corporation","status":"reported-late","is_pact":false,"days_late":130},{"registry_id":"NCT01330446","publication_url":"https://clinicaltrials.gov/study/NCT01330446","title":"Armodafinil for Persistent Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer: a Randomized Phase II Study","has_exemption":false,"start_date":"2011-05-19","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02723331","publication_url":"https://clinicaltrials.gov/study/NCT02723331","title":"Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates","has_exemption":true,"start_date":"2016-12-30","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Academic Thoracic Oncology Medical Investigators Consortium","sponsor_slug":"academic-thoracic-oncology-medical-investigators-consortium","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04028765","publication_url":"https://clinicaltrials.gov/study/NCT04028765","title":"POM PROM: Pitocin or Oral Misoprostol for PROM IOL in Nulliparous Women With Unfavorable Cervical Exams","has_exemption":true,"start_date":"2019-08-12","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04104321","publication_url":"https://clinicaltrials.gov/study/NCT04104321","title":"A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy PK, Kinetics and Safety of Aramchol in Nonalcoholic Steatohepatitis (NASH) With Open-Label Part","has_exemption":false,"start_date":"2019-09-23","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Galmed Research and Development, Ltd.","sponsor_slug":"galmed-research-and-development-ltd","status":"reported-late","is_pact":false,"days_late":300},{"registry_id":"NCT04786340","publication_url":"https://clinicaltrials.gov/study/NCT04786340","title":"A Randomized, Double-blind, Placebo-controlled, Parallel, 12-week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetes Mellitus Patients With Painful Peripheral Neuropathy","has_exemption":true,"start_date":"2020-11-20","completion_date":"2022-12-08","has_results":false,"results_due":true,"sponsor_name":"WinSanTor, Inc","sponsor_slug":"winsantor-inc","status":"overdue","is_pact":false,"days_late":108},{"registry_id":"NCT04601532","publication_url":"https://clinicaltrials.gov/study/NCT04601532","title":"Randomized Controlled Trial Assessing a Novel Glycopolymer Compound in the Treatment of Superficial Partial-thickness Burns","has_exemption":false,"start_date":"2021-06-11","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"J. Peter Rubin, MD","sponsor_slug":"j-peter-rubin-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04729972","publication_url":"https://clinicaltrials.gov/study/NCT04729972","title":"Phase II, Multicenter, Open-label Safety Study of Bilateral NT-501 in Participants With Macular Telangiectasia Type 2","has_exemption":false,"start_date":"2021-07-21","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Neurotech Pharmaceuticals","sponsor_slug":"neurotech-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":229},{"registry_id":"NCT05055453","publication_url":"https://clinicaltrials.gov/study/NCT05055453","title":"ESolutions Functions for Children and Young People With the myPhonak App","has_exemption":false,"start_date":"2021-10-04","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Sonova AG","sponsor_slug":"sonova-ag","status":"reported-late","is_pact":false,"days_late":129},{"registry_id":"NCT05038904","publication_url":"https://clinicaltrials.gov/study/NCT05038904","title":"Preventing Life-Threatening Allergic Reactions With Acalabrutinib, an FDA-Approved Bruton's Tyrosine Kinase Inhibitor","has_exemption":false,"start_date":"2021-12-16","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05309694","publication_url":"https://clinicaltrials.gov/study/NCT05309694","title":"A Post-Marketing, Prospective, Multi-Center, Single Arm, Open Label Clinical Study to Evaluate the Safety of a New Inserter Design for Paragard® T380A Intrauterine Copper Contraceptive","has_exemption":false,"start_date":"2022-03-04","completion_date":"2022-12-08","has_results":false,"results_due":true,"sponsor_name":"CooperSurgical Inc.","sponsor_slug":"coopersurgical-inc","status":"overdue","is_pact":false,"days_late":839},{"registry_id":"NCT05445128","publication_url":"https://clinicaltrials.gov/study/NCT05445128","title":"A Phase 2, Open-Label Study to Evaluate the Efficacy and Safety of MGTA-145 in Combination With Plerixafor for the Mobilization of Hematopoietic Stem Cells in Patients With Sickle Cell Disease","has_exemption":false,"start_date":"2022-06-24","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Ensoma","sponsor_slug":"ensoma","status":"reported-late","is_pact":false,"days_late":559},{"registry_id":"NCT05376215","publication_url":"https://clinicaltrials.gov/study/NCT05376215","title":"A Comparison of Hearing Aid Fitting Methods","has_exemption":false,"start_date":"2022-08-17","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Sonova AG","sponsor_slug":"sonova-ag","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05582304","publication_url":"https://clinicaltrials.gov/study/NCT05582304","title":"Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study","has_exemption":false,"start_date":"2022-10-31","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04912232","publication_url":"https://clinicaltrials.gov/study/NCT04912232","title":"Continued Development of a Multiplex Precision Medicine System for Early Warning of Progression Toward Hemodynamic Deterioration After Trauma","has_exemption":false,"start_date":"2022-12-08","completion_date":"2022-12-08","has_results":true,"results_due":true,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01793129","publication_url":"https://clinicaltrials.gov/study/NCT01793129","title":"A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.","has_exemption":false,"start_date":"2015-05-31","completion_date":"2022-12-09","has_results":true,"results_due":true,"sponsor_name":"NICHD Neonatal Research Network","sponsor_slug":"nichd-neonatal-research-network","status":"reported-late","is_pact":true,"days_late":25},{"registry_id":"NCT03606486","publication_url":"https://clinicaltrials.gov/study/NCT03606486","title":"Lavage of the Uterine Cavity for Diagnosis of Ovarian Carcinomas","has_exemption":false,"start_date":"2018-11-16","completion_date":"2022-12-09","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":false,"days_late":null}]}